It's a copycat killer—often mimicking less severe conditions and delaying much-needed, timely treatments. But sepsis—an ...

EPALINGES, Switzerland--(BUSINESS WIRE)--Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, announced today that its IVD CAPSULE PSP test has received ...

Clinicians lack methods for early detection of sepsis, a dysregulated response to infection that can result in life-threatening organ failure if treatment is delayed. New research published in The ...

Sepsis is the body’s overwhelming and life-threatening response to infection, which may rapidly lead to tissue damage, organ failure and death. In the United States alone, sepsis is attributed to more ...

Clinicians lack methods for early detection of sepsis, a dysregulated response to infection that can result in life-threatening organ failure if treatment is delayed. New research published in The ...

A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including ...

“Sepsis is more deadly than heart attack and stroke combined — in fact it’s the deadliest, costliest, and arguably most complex condition facing hospitals today.” IntelliSep was cleared by the FDA in ...

Please provide your email address to receive an email when new articles are posted on . IL-6 levels peak 6 hours after infection, compared with 24 hours for traditional biomarkers. The biomarker was ...

Scientists from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago and colleagues identified several proteins from the umbilical cord blood of preterm ...

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...